Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
CNY 20.08
(-0.74%)
CNY 20.08
(-0.74%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 52.67 Billion CNY | 37.67% |
| 2022 | 38.26 Billion CNY | 24.83% |
| 2021 | 30.65 Billion CNY | 101.79% |
| 2020 | 15.19 Billion CNY | 43.48% |
| 2019 | 10.58 Billion CNY | 102.5% |
| 2018 | 5.22 Billion CNY | 289.43% |
| 2017 | 1.34 Billion CNY | 201.06% |
| 2016 | 445.94 Million CNY | -37.43% |
| 2015 | 712.73 Million CNY | -11.01% |
| 2014 | 800.93 Million CNY | 2.66% |
| 2013 | 780.17 Million CNY | 2.03% |
| 2012 | 764.61 Million CNY | 21.61% |
| 2011 | 628.74 Million CNY | -14.73% |
| 2010 | 737.31 Million CNY | 22.06% |
| 2009 | 604.04 Million CNY | 2.32% |
| 2008 | 590.33 Million CNY | 19.88% |
| 2007 | 492.42 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 4.52 Billion CNY | -34.02% |
| 2024 Q2 | 6.86 Billion CNY | -39.51% |
| 2024 Q1 | 11.34 Billion CNY | -16.47% |
| 2023 Q2 | 13.27 Billion CNY | 18.79% |
| 2023 Q3 | 14.82 Billion CNY | 11.71% |
| 2023 Q4 | 13.58 Billion CNY | -8.39% |
| 2023 FY | 52.67 Billion CNY | 37.67% |
| 2023 Q1 | 11.17 Billion CNY | 7.01% |
| 2022 Q2 | 9.51 Billion CNY | 7.59% |
| 2022 Q3 | 9.46 Billion CNY | -0.45% |
| 2022 Q4 | 10.44 Billion CNY | 10.26% |
| 2022 FY | 38.26 Billion CNY | 24.83% |
| 2022 Q1 | 8.84 Billion CNY | 0.2% |
| 2021 Q1 | 3.92 Billion CNY | -5.17% |
| 2021 Q3 | 8.65 Billion CNY | -6.36% |
| 2021 Q4 | 8.82 Billion CNY | 1.92% |
| 2021 FY | 30.65 Billion CNY | 101.79% |
| 2021 Q2 | 9.24 Billion CNY | 135.44% |
| 2020 Q3 | 4.05 Billion CNY | -6.95% |
| 2020 Q2 | 4.35 Billion CNY | 65.46% |
| 2020 Q1 | 2.63 Billion CNY | -9.81% |
| 2020 FY | 15.19 Billion CNY | 43.48% |
| 2020 Q4 | 4.14 Billion CNY | 2.08% |
| 2019 Q4 | 2.92 Billion CNY | 11.18% |
| 2019 FY | 10.58 Billion CNY | 102.5% |
| 2019 Q3 | 2.62 Billion CNY | -4.29% |
| 2019 Q2 | 2.74 Billion CNY | 19.69% |
| 2019 Q1 | 2.29 Billion CNY | 32.31% |
| 2018 Q2 | 1.23 Billion CNY | 47.14% |
| 2018 Q3 | 1.42 Billion CNY | 15.36% |
| 2018 FY | 5.22 Billion CNY | 289.43% |
| 2018 Q1 | 838.32 Million CNY | 46.17% |
| 2018 Q4 | 1.73 Billion CNY | 21.81% |
| 2017 Q4 | 573.51 Million CNY | 77.07% |
| 2017 Q3 | 323.89 Million CNY | 14.48% |
| 2017 FY | 1.34 Billion CNY | 201.06% |
| 2017 Q1 | 162.23 Million CNY | -6.07% |
| 2017 Q2 | 282.92 Million CNY | 74.39% |
| 2016 FY | 445.94 Million CNY | -37.43% |
| 2016 Q4 | 172.71 Million CNY | 93.43% |
| 2016 Q3 | 89.28 Million CNY | 121.97% |
| 2016 Q2 | 40.22 Million CNY | -72.01% |
| 2016 Q1 | 143.71 Million CNY | -8.75% |
| 2015 Q3 | 170.62 Million CNY | -9.31% |
| 2015 Q4 | 157.49 Million CNY | -7.69% |
| 2015 FY | 712.73 Million CNY | -11.01% |
| 2015 Q1 | 196.47 Million CNY | -12.19% |
| 2015 Q2 | 188.14 Million CNY | -4.24% |
| 2014 Q3 | 196.7 Million CNY | -9.7% |
| 2014 FY | 800.93 Million CNY | 2.66% |
| 2014 Q1 | 162.67 Million CNY | -18.62% |
| 2014 Q2 | 217.82 Million CNY | 33.9% |
| 2014 Q4 | 223.73 Million CNY | 13.74% |
| 2013 Q3 | 154.7 Million CNY | -35.81% |
| 2013 FY | 780.17 Million CNY | 2.03% |
| 2013 Q1 | 184.54 Million CNY | -31.05% |
| 2013 Q2 | 241.02 Million CNY | 30.6% |
| 2013 Q4 | 199.89 Million CNY | 29.2% |
| 2012 Q1 | 138.57 Million CNY | -19.48% |
| 2012 FY | 764.61 Million CNY | 21.61% |
| 2012 Q2 | 189.41 Million CNY | 36.69% |
| 2012 Q3 | 168.97 Million CNY | -10.79% |
| 2012 Q4 | 267.65 Million CNY | 58.41% |
| 2011 Q4 | 172.08 Million CNY | 19.37% |
| 2011 Q3 | 144.16 Million CNY | -21.53% |
| 2011 Q2 | 183.73 Million CNY | 42.7% |
| 2011 Q1 | 128.75 Million CNY | -51.41% |
| 2011 FY | 628.74 Million CNY | -14.73% |
| 2010 Q3 | 141.49 Million CNY | -36.97% |
| 2010 Q2 | 224.48 Million CNY | 111.1% |
| 2010 Q1 | 106.33 Million CNY | -42.7% |
| 2010 FY | 737.31 Million CNY | 22.06% |
| 2010 Q4 | 264.99 Million CNY | 87.28% |
| 2009 Q4 | 185.58 Million CNY | 30.77% |
| 2009 Q3 | 141.91 Million CNY | 0.0% |
| 2009 FY | 604.04 Million CNY | 2.32% |
| 2008 FY | 590.33 Million CNY | 19.88% |
| 2007 FY | 492.42 Million CNY | 0.0% |